West Pharmaceutical Services PE Ratio 2010-2024 | WST

Current and historical p/e ratio for West Pharmaceutical Services (WST) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. West Pharmaceutical Services PE ratio as of January 29, 2025 is 50.23.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

West Pharmaceutical Services PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-01-30 343.91 51.03
2024-09-30 299.98 $6.74 44.51
2024-06-30 328.97 $7.03 46.80
2024-03-31 395.01 $7.58 52.11
2023-12-31 351.31 $7.88 44.58
2023-09-30 374.35 $7.41 50.52
2023-06-30 381.40 $6.86 55.60
2023-03-31 345.31 $7.28 47.43
2022-12-31 234.39 $7.72 30.36
2022-09-30 244.87 $8.29 29.54
2022-06-30 300.70 $9.01 33.37
2022-03-31 408.25 $9.00 45.36
2021-12-31 465.98 $8.70 53.56
2021-09-30 421.61 $8.06 52.31
2021-06-30 356.46 $6.84 52.11
2021-03-31 279.56 $5.58 50.10
2020-12-31 280.92 $4.58 61.34
2020-09-30 272.42 $4.13 65.96
2020-06-30 224.98 $3.79 59.36
2020-03-31 150.64 $3.46 43.54
2019-12-31 148.59 $3.20 46.43
2019-09-30 140.01 $3.05 45.91
2019-06-30 123.41 $3.03 40.73
2019-03-31 108.52 $2.90 37.42
2018-12-31 96.40 $2.75 35.05
2018-09-30 121.26 $2.06 58.86
2018-06-30 97.37 $2.00 48.69
2018-03-31 86.45 $1.76 49.12
2017-12-31 96.48 $1.99 48.48
2017-09-30 93.98 $2.51 37.44
2017-06-30 92.15 $2.34 39.38
2017-03-31 79.44 $2.43 32.69
2016-12-31 82.45 $1.92 42.94
2016-09-30 72.28 $1.85 39.07
2016-06-30 73.50 $1.37 53.65
2016-03-31 67.04 $1.15 58.29
2015-12-31 58.11 $1.30 44.70
2015-09-30 52.11 $1.28 40.71
2015-06-30 55.83 $1.69 33.03
2015-03-31 57.76 $1.83 31.56
2014-12-31 50.97 $1.76 28.96
2014-09-30 42.74 $1.66 25.75
2014-06-30 40.18 $1.60 25.11
2014-03-31 41.86 $1.51 27.73
2013-12-31 46.53 $1.58 29.45
2013-09-30 38.95 $1.55 25.13
2013-06-30 33.16 $1.40 23.77
2013-03-31 30.56 $1.19 25.68
2012-12-31 25.68 $1.15 22.42
2012-09-30 24.80 $1.12 22.24
2012-06-30 23.51 $1.15 20.53
2012-03-31 19.72 $1.21 16.36
2011-12-31 17.51 $1.08 16.21
2011-09-30 17.04 $0.90 18.93
2011-06-30 20.02 $0.91 22.00
2011-03-31 20.40 $0.94 21.82
2010-12-31 18.70 $0.94 19.89
2010-09-30 15.50 $1.15 13.54
2010-06-30 16.41 $1.14 14.39
2010-03-31 18.79 $1.12 16.86
2009-12-31 17.49 $1.06 16.50
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $24.592B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $76.568B 20.89
Becton Dickinson (BDX) United States $71.603B 18.76
Cardinal Health (CAH) United States $30.919B 16.77
Straumann Holding AG (SAUHY) Switzerland $23.137B 0.00
Labcorp (LH) United States $20.594B 17.08
Cooper (COO) United States $19.559B 26.49
Align Technology (ALGN) United States $16.756B 32.06
Henry Schein (HSIC) United States $9.958B 18.97
Merit Medical Systems (MMSI) United States $6.322B 32.29
DENTSPLY SIRONA (XRAY) United States $3.902B 10.61
Patterson (PDCO) United States $2.733B 14.60
CONMED (CNMD) United States $2.174B 18.14
STAAR Surgical (STAA) United States $1.192B 43.98
Lifevantage (LFVN) United States $0.274B 36.50
Pro-Dex (PDEX) United States $0.141B 28.09